Fulcrum Therapeutics (FULC) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $3.65, -0.54% vs the prior close of $3.67.
- Volume 1.39M shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
FULC dips 0.5% to $3.65, a 1-month low, 5 down days in a row. Closed at $3.65, -0.54% vs the prior close of $3.67. Day range $3.64–$3.68, opened at $3.68.
FULC daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — FULC dips 0.5% to $3.65, a 1-month low, 5 down days in a row
- Closed at $3.65, -0.54% vs the prior close of $3.67. Day range $3.64–$3.68, opened at $3.68.
- Volume was 1.39M shares, 0.9x its 50-day average of 1.55M.
- Price is -3.4% vs its 50-day average ($3.78) and -41.1% vs its 200-day average ($6.19).
- 52-week range $2.83–$15.74; today's close sits at 6% of that range, 76.8% below the 52-week high.
- That makes 5 straight losses.
Oct 15, 2026 — FULC ends flat (+0.0%) to $3.67, 4 down days in a row
- Closed at $3.67, +0.00% vs the prior close of $3.67. Day range $3.66–$3.72, opened at $3.71.
- Volume was 1.23M shares, 0.8x its 50-day average of 1.55M.
- Price is -3.0% vs its 50-day average ($3.78) and -41.1% vs its 200-day average ($6.23).
- 52-week range $2.83–$15.74; today's close sits at 7% of that range, 76.7% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 — FULC ends flat (-0.3%) to $3.67, 3 down days in a row
- Closed at $3.67, -0.27% vs the prior close of $3.68. Day range $3.65–$3.71, opened at $3.67.
- Volume was 1.66M shares, 1.1x its 50-day average of 1.56M.
- Price is -3.0% vs its 50-day average ($3.78) and -41.5% vs its 200-day average ($6.27).
- 52-week range $2.83–$15.74; today's close sits at 7% of that range, 76.7% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — FULC dips 1.9% to $3.68
- Closed at $3.68, -1.87% vs the prior close of $3.75. Day range $3.67–$3.75, opened at $3.75.
- Volume was 1.46M shares, 0.9x its 50-day average of 1.58M.
- Price is -2.8% vs its 50-day average ($3.79) and -41.7% vs its 200-day average ($6.31).
- 52-week range $2.83–$15.74; today's close sits at 7% of that range, 76.6% below the 52-week high.
Oct 12, 2026 — FULC dips 0.5% to $3.75
- Closed at $3.75, -0.53% vs the prior close of $3.77. Day range $3.73–$3.77, opened at $3.77.
- Volume was 1.61M shares, 1.0x its 50-day average of 1.62M.
- Price is -1.0% vs its 50-day average ($3.79) and -41.0% vs its 200-day average ($6.36).
- 52-week range $2.83–$15.74; today's close sits at 7% of that range, 76.2% below the 52-week high.
Oct 9, 2026 — FULC rises 0.5% to $3.77
- Closed at $3.77, +0.53% vs the prior close of $3.75. Day range $3.72–$3.79, opened at $3.75.
- Volume was 1.80M shares, 1.1x its 50-day average of 1.60M.
- Price is -0.4% vs its 50-day average ($3.78) and -41.1% vs its 200-day average ($6.40).
- 52-week range $2.83–$15.74; today's close sits at 7% of that range, 76.0% below the 52-week high.
Oct 8, 2026 — FULC rises 2.2% to $3.75
- Closed at $3.75, +2.18% vs the prior close of $3.67. Day range $3.66–$3.78, opened at $3.66.
- Volume was 2.63M shares, 1.7x its 50-day average of 1.57M.
- Price is -0.9% vs its 50-day average ($3.78) and -41.8% vs its 200-day average ($6.44).
- 52-week range $2.83–$15.74; today's close sits at 7% of that range, 76.2% below the 52-week high.
Oct 7, 2026 — FULC dips 0.5% to $3.67, a 1-month low
- Closed at $3.67, -0.54% vs the prior close of $3.69. Day range $3.67–$3.72, opened at $3.70.
- Volume was 1.04M shares, 0.7x its 50-day average of 1.58M.
- Price is -2.9% vs its 50-day average ($3.78) and -43.4% vs its 200-day average ($6.48).
- 52-week range $2.83–$15.74; today's close sits at 7% of that range, 76.7% below the 52-week high.
Oct 6, 2026 — FULC dips 0.5% to $3.69
- Closed at $3.69, -0.54% vs the prior close of $3.71. Day range $3.68–$3.72, opened at $3.72.
- Volume was 757.00K shares, 0.5x its 50-day average of 1.57M — lighter than usual.
- Price is -2.4% vs its 50-day average ($3.78) and -43.5% vs its 200-day average ($6.53).
- 52-week range $2.83–$15.74; today's close sits at 7% of that range, 76.6% below the 52-week high.
Oct 5, 2026 — FULC rises 0.5% to $3.71
- Closed at $3.71, +0.54% vs the prior close of $3.69. Day range $3.68–$3.73, opened at $3.70.
- Volume was 1.06M shares, 0.7x its 50-day average of 1.56M.
- Price is -1.9% vs its 50-day average ($3.78) and -43.5% vs its 200-day average ($6.57).
- 52-week range $2.83–$15.74; today's close sits at 7% of that range, 76.4% below the 52-week high.
Oct 2, 2026 — FULC ends flat (+0.3%) to $3.69
- Closed at $3.69, +0.27% vs the prior close of $3.68. Day range $3.65–$3.76, opened at $3.72.
- Volume was 1.54M shares, 1.0x its 50-day average of 1.55M.
- Price is -2.4% vs its 50-day average ($3.78) and -44.2% vs its 200-day average ($6.61).
- 52-week range $2.83–$15.74; today's close sits at 7% of that range, 76.6% below the 52-week high.
FULC latest news & SEC filings
Every SEC filing by or about FULC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 2, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
- Item 5.01 — Change in control of the company.
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 3, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 30, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$26.18M (prior year -$17.30M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.34 (prior year -$0.28) (loss widened vs Jun 30, 2025)
Jul 28, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade FULC
- Last results release: Apr 27, 2026 (8-K Item 2.02). Previous ones: Feb 24, 2026, Jan 12, 2026, Oct 29, 2025. Based on that rhythm, the next report is likely around Jul 27, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.71% (largest 2.2%). That is a relatively calm stock.
- Liquidity: about 1.47M shares (≈$5.37M) trade per day on average.
- 52-week position: $3.65 vs a range of $2.83–$15.74 (6% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Kevin Tang bought 50,945 shares on Jul 17, 2026.
- Latest filings: 8-K Aug 17, 2026; 8-K Aug 10, 2026; 10-Q Jul 30, 2026.
- Share count: 76.30M shares outstanding (Jul 23, 2026), +41.1% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
FULC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 3.68 | 3.68 | 3.64 | 3.65 | 1.39M |
| Oct 15, 2026 | 3.71 | 3.72 | 3.66 | 3.67 | 1.23M |
| Oct 14, 2026 | 3.67 | 3.71 | 3.65 | 3.67 | 1.66M |
| Oct 13, 2026 | 3.75 | 3.75 | 3.67 | 3.68 | 1.46M |
| Oct 12, 2026 | 3.77 | 3.77 | 3.73 | 3.75 | 1.61M |
| Oct 9, 2026 | 3.75 | 3.79 | 3.72 | 3.77 | 1.80M |
| Oct 8, 2026 | 3.66 | 3.78 | 3.66 | 3.75 | 2.63M |
| Oct 7, 2026 | 3.70 | 3.72 | 3.67 | 3.67 | 1.04M |
| Oct 6, 2026 | 3.72 | 3.72 | 3.68 | 3.69 | 757.00K |
| Oct 5, 2026 | 3.70 | 3.73 | 3.68 | 3.71 | 1.06M |
| Oct 2, 2026 | 3.72 | 3.76 | 3.65 | 3.69 | 1.54M |
| Oct 1, 2026 | 3.70 | 3.72 | 3.67 | 3.68 | 1.23M |
| Sep 30, 2026 | 3.73 | 3.73 | 3.66 | 3.70 | 1.92M |
| Sep 29, 2026 | 3.73 | 3.79 | 3.68 | 3.70 | 1.84M |
| Sep 28, 2026 | 3.75 | 3.76 | 3.71 | 3.72 | 901.20K |
| Sep 25, 2026 | 3.80 | 3.81 | 3.71 | 3.74 | 2.49M |
| Sep 24, 2026 | 3.82 | 3.82 | 3.74 | 3.79 | 1.95M |
| Sep 23, 2026 | 3.86 | 3.86 | 3.80 | 3.81 | 1.19M |
| Sep 22, 2026 | 3.80 | 3.85 | 3.79 | 3.84 | 978.90K |
| Sep 21, 2026 | 3.80 | 3.80 | 3.75 | 3.80 | 731.40K |
About Fulcrum Therapeutics
Fulcrum Therapeutics (FULC) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in CAMBRIDGE, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1680581.
FULC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Sonja Banks | Director | Jul 2, 2026 |
| Katina Dorton | Director | Jul 2, 2026 |
| Alan Ezekowitz | Director | Jul 2, 2026 |
| James A Geraghty | Director | Jul 2, 2026 |
| Robert J Gould | Director | Jul 2, 2026 |
| Kate Haviland | Director | Jul 2, 2026 |
| Colin Hill | Director | Jul 2, 2026 |
| Rachel K. King | Director | Jul 2, 2026 |
| Joshua Lehrer-Graiwer | Director | May 1, 2026 |
| Alex Sapir | See Remarks | Feb 4, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Alan A Musso | Chief Financial Officer | Feb 4, 2026 |
| Curtis Gale Oltmans | Chief Legal Officer | Feb 4, 2026 |
| Alex Sapir | See Remarks | Feb 4, 2026 |
| Greg Tourangeau | Principal Accounting Officer | Feb 4, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 17, 2026 | Kevin Tang | Buy | 50,945 | $3.52 |
| Jul 17, 2026 | Kevin Tang | Buy | 50,945 | $3.52 |
| Jul 17, 2026 | Capital Management Llc Tang | Buy | 50,945 | $3.52 |
| Jul 17, 2026 | Capital Management Llc Tang | Buy | 50,945 | $3.52 |
| Jul 17, 2026 | Kevin Tang | Buy | 50,945 | $3.52 |
| Jul 17, 2026 | Kevin Tang | Buy | 50,945 | $3.52 |
| Jul 17, 2026 | Capital Management Llc Tang | Buy | 50,945 | $3.52 |
| Jul 17, 2026 | Capital Management Llc Tang | Buy | 50,945 | $3.52 |
| Jul 16, 2026 | Kevin Tang | Buy | 116,671 | $3.56 |
| Jul 16, 2026 | Kevin Tang | Buy | 116,671 | $3.56 |
| Jul 16, 2026 | Capital Management Llc Tang | Buy | 116,671 | $3.56 |
| Jul 16, 2026 | Capital Management Llc Tang | Buy | 116,671 | $3.56 |
| Jul 16, 2026 | Kevin Tang | Buy | 116,671 | $3.56 |
| Jul 16, 2026 | Kevin Tang | Buy | 116,671 | $3.56 |
| Jul 16, 2026 | Capital Management Llc Tang | Buy | 116,671 | $3.56 |
FULC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-74.88M | -1.18 | $-60.06M |
| Dec 31, 2024 | — | $-9.72M | -0.16 | $-2.22M |
| Dec 31, 2023 | — | $-97.33M | -1.59 | $-90.97M |
| Dec 31, 2022 | — | $-109.87M | -2.44 | $-97.05M |
| Dec 31, 2021 | — | $-80.85M | -2.29 | $-78.48M |
Latest balance sheet: total assets $323.95M, total liabilities $13.26M, cash $48.47M (as of Jun 30, 2026).
FULC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Apr 27, 2026 | 8-K Item 2.02 (results) | $7.72 |
| Feb 24, 2026 | 8-K Item 2.02 (results) | $8.58 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $9.51 |
| Oct 29, 2025 | 8-K Item 2.02 (results) | $9.36 |
| Jul 29, 2025 | 8-K Item 2.02 (results) | $7.59 |
| May 1, 2025 | 8-K Item 2.02 (results) | $4.38 |
| Feb 25, 2025 | 8-K Item 2.02 (results) | $3.70 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $4.17 |
| Nov 13, 2024 | 8-K Item 2.02 (results) | $3.56 |
| Jul 31, 2024 | 8-K Item 2.02 (results) | — |
| May 13, 2024 | 8-K Item 2.02 (results) | — |
| Feb 27, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on FULC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.